Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NRARP is a protein that functions as a feedback inhibitor of the Notch signaling pathway. It interacts with components of the Notch transcriptional activation complex, specifically NICD and RBPJ, inhibiting the expression of Notch target genes. It also integrates signals from the Wnt pathway, playing a role in angiogenesis and vascular development. Dysregulation of NRARP has been implicated in spondylocostal dysostosis and certain cancers, including leukemia and breast cancer.
Inhibits CBF-1-mediated transcriptional activation by binding to NICD and RBPJ, potentially promoting NICD degradation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NOTCH regulated ankyrin repeat protein (NRARP).